Lisa: I follow a vitiligo management plan developed with my dermatologist where I use Opzelura ® (ruxolitinib) cream 1.5%. I first noticed some repigmentation, particularly on my face ...

Another JAK inhibitor -- ruxolitinib -- is already approved as a topical formulation (Opzelura) to treat vitiligo. But the indication is only for vitiligo affecting the face and no more than 10% ...

Incyte has made further progress with its ruxolitinib cream, notching up a phase 3 trial showing it can re-pigment skin in vitiligo ahead of a key FDA decision in atopic dermatitis.

It is not known if OPZELURA is safe and effective in children less than 12 years of age with nonsegmental vitiligo. Serious Infections: OPZELURA contains ruxolitinib. Ruxolitinib belongs to a ...

Last year, Incyte became the first pharma company to get approval for a drug that can re-pigment the skin in vitiligo – topical JAK1/JAK2 inhibitor Opzelura (ruxolitinib) – for patients whose ...

Vitiligo on the penis occurs when patches ... pimecrolimus, and Opzelura (ruxolitinib) which affect your body's immune response. You should only use a topical medication on your penis if your ...

Opzelura is a treatment for nonsegmental vitiligo in patients 12 and older, making it the first and only cream in the U.S.

In 2022, the FDA approved the first re-pigmentation therapy for vitiligo: Opzelura (ruxolitinib) cream. Clinical trials found that only 30% of patients using the cream regained 75% or more skin re ...

Incyte’s ruxolitinib franchise, made up of blockbuster JAK inhibitor Jakafi and its topical counterpart Opzelura, have been ...